This week, 23andMe, the Google-backed DTC genetic test company, stunned many observers by agreeing to stop sales of its $99 genetic test kit online, saying it will now release only ancestry information and raw data without interpretation.
Today, the FDA shut down further sales of the saliva home-test kit, citing the "potential health consequences that could result from false positive or false negative assessments for high-risk indications.
Congress should consider amending the patent law to appoint ethical representatives to the PTO. Its present staff, given their alternative professional backgrounds and competing professional responsibilities, cannot reasonably be expected to account for the relevant methodology and literature.
I see personal genomics more generally evolving rapidly to become a major part of everyday life for Americans and around the globe. At the same time, potential problems associated with it will continue to emerge in parallel and merit serious evaluation.
In my first piece on personal genomics, I wrote about how data on one's genome can provide information on one's disease risk. Such personal genomics studies estimate the probability of someone getting a disease.
Giving birth, whether in medically-advanced countries or in the developing world, is shrouded in mystery. Women have to face pregnancy with a "wait and see" approach to whether it will go well, or not.